Phase 2b
The VBP15-004 clinical trial is currently enrolling at 34 sites in the following 11 countries:
- Canada (4 sites)
- USA (11 sites)
- United Kingdom (6 sites)
- Netherlands (2 sites)
- Belgium (2 sites)
- Sweden (1 site)
- Israel (1 sites)
- Australia (2 sites)
- Spain (2 sites)
- Czech Republic (2 sites)
- Greece (1 site)
It is anticipated that enrollment will fill by the end of 2019 or early 2020.
Details on sites and contact information is found on clinicaltrials.gov
https://clinicaltrials.gov/ct2/show/NCT03439670
